InnovAge Holding Corp.
INNV Nasdaq
SEC CIK 1834376
Follow InnovAge Holding Corp.
Weekly email: filings, results
Revenue, last quarter
$264.8M
+12.1% vs same quarter last year
Net income
$19.6M
+143.8% vs same quarter last year
EPS, diluted
$0.14
+133.3% vs same quarter last year
Operating cash flow
$28.7M
+632.5% vs same quarter last year
Source: SEC XBRL filings · latest filing
- Revenue
- Net income
Show the numbers
| Year | Revenue | Net income |
|---|---|---|
| FY26 | $989.7M | −$2.5M |
| FY25 | $853.7M | −$30.3M |
| FY24 | $763.9M | −$21.3M |
| FY23 | $688.1M | −$40.7M |
| FY22 | $698.6M | −$6.5M |
| FY21 | $637.8M | −$44M |
| FY20 | $567.2M | $26.3M |
| FY19 | - | - |
- Gross margin
- Operating margin
- Net margin
Show the numbers
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| FY26 | 23% | 0.3% | −0.3% |
| FY25 | 18% | −3.5% | −3.6% |
| FY24 | 17.3% | −3% | −2.8% |
| FY23 | 14.7% | −7.2% | −5.9% |
| FY22 | 19.4% | −0.6% | −0.9% |
| FY21 | - | −1.9% | −6.9% |
| FY20 | - | 9% | 4.6% |
| FY19 | - | - | - |
Show the numbers
| Year | Free cash flow |
|---|---|
| FY26 | $50.4M |
| FY25 | $26.6M |
| FY24 | −$44.8M |
| FY23 | −$3.1M |
| FY22 | −$10.9M |
| FY21 | −$25.1M |
| FY20 | $32M |
| FY19 | - |
- InnovAge Holding Corp.
- Healthcare median
Show the numbers
| Year | InnovAge Holding Corp. | Healthcare median |
|---|---|---|
| FY26 | −0.3% | −11.1% |
| FY25 | −3.6% | −30.6% |
| FY24 | −2.8% | −47% |
| FY23 | −5.9% | −58% |
| FY22 | −0.9% | −80.4% |
| FY21 | −6.9% | −71.8% |
| FY20 | 4.6% | −62.2% |
| FY19 | - | −46.2% |